Relationship between IL- 28B polymorphisms and susceptibility to hepatitis C among Han population in Jiangsu Province, China
-
摘要: 目的探讨江苏地区汉族人群白细胞介素(IL)28B基因多态性分布及其与丙型肝炎易感性的关系。方法选取2011年南京市第二医院就诊的丙型肝炎患者88名,体检中心健康体检的健康人群100例。应用聚合酶链式反应(PCR)和直接测序法检测丙型肝炎患者和健康人群IL-28B rs8099917、rs12979860、rs12980275、rs8113007和rs12972991位点的单核苷酸多态性(SNP),并统计分析这些位点的基因型和等位基因在两种不同人群中分布的差异。采用Pearsonχ2检验进行分析,计算Hardy-Weinberg遗传平衡以判断样本的代表性。结果两者间性别和年龄差异均无统计学意义(P=0.92、0.28),在检测人群中IL-28B基因5个位点的主要基因型分别是TT、CC、AA、AA、AA;丙型肝炎患者IL-28B基因SNP位点与健康人群在基因型(χ2=0.31、0.50、0.60、0.15、0.07,P均>0.05)和等位基因(χ2=0.29、0.48、0.56、0.14、0.07,P均>0.05)分布上差异均无统计学意义。结论 IL-28B的SNPs位点(rs...Abstract: Objective To investigate the association between interleukin- 28B ( IL- 28B) polymorphisms and susceptibility to hepatitis C among the Han population in Jiangsu Province, China. Methods A case- control study was conducted in 88 hepatitis C patients who visited the Second Hospital of Nanjing in 2011 and 100 healthy controls who underwent physical examination in the same hospital. PCR and direct sequencing were used to detect IL- 28B single- nucleotide polymorphisms ( SNPs) ( rs8099917, rs12979860, rs12980275, rs8113007, and rs12972991) . Genotypes and alleles were compared between the two groups. Statistical analysis was performed by Pearsonχ2test; the sample representativeness was evaluated according to the Hardy- Weinberg equilibrium. Results There were no significant differences in sex and age between the two groups ( P = 0. 92 and 0. 28) . The major genotypes at the five IL- 28B SNPs among subjects were TT, CC, AA, AA, and AA. No significant differences were observed between hepatitis C patients and healthy controls in the genotypes and alleles at these IL- 28B SNPs ( χ2= 0. 31, 0. 50, 0. 60, 0. 15, and 0. 07, P > 0. 05 for all; χ2= 0. 29, 0. 48, 0. 56, 0. 14, and 0. 07, P >0. 05 for all) . Conclusion IL- 28B SNPs ( rs8099917, rs12979860, rs12980275, rs8113007, and rs12972991) may not be associated with the susceptibility to hepatitis C among the Han population in Jiangsu Province.
-
[1]LAUER GM, WALKER BD.Hepatitis C virus infection[J].N Engl J Med, 2001, 345 (1) :41-52. [2] SHEPPARD P, KINDSVOGEL W, XU W, et al.IL-28, IL-29and their class II cytokine receptor IL-28R[J].Nat Immunol, 2003, 4 (1) :63-68. [3] GE D, FELLAY J, THOMPSON AJ, et al.Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance[J].Nature, 2009, 461 (7262) :399-401. [4] THOMAS DL, THIO CL, MARTIN MP, et al.Genetic variation in IL28B and spontaneous clearance of hepatitis C virus[J].Nature, 2009, 461 (7265) :798-801. [5] SUPPIAH V, MOLDOVAN M, AHLENSTIEL G, et al.IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy[J].Nat Genet, 2009, 41 (9) :1100-1104. [6] TANAKA Y, NISHIDA N, SUGIYAMA M, et al.Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C[J].Nat Genet, 2009, 41 (10) :1105-1109. [7]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].J Clin Hepatol, 2004, 20 (4) :197-203. (in Chinese) 中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].临床肝胆病杂志, 2004, 20 (4) :197-203. [8]NIE YH, XU CM.HCV genetic heterogeneity and its host genetics[J].J Clin Hepatol, 2013, 29 (10) :797-800. (in Chinese) 聂永红, 许春梅.HCV异质性及其宿主基因多态性[J].临床肝胆病杂志, 2013, 29 (10) :797-800. [9]PAN QC, YU YS, TANG ZH, et al.Serum IL-21 levels in patients with chronic hepatitis C and clinical significance of IL-21[J].Chin J Clin Pharmacol Ther, 2013, 18 (2) :190-194. (in Chinese) 潘庆春, 余永胜, 汤正好, 等.慢性丙型肝炎患者血清IL-21水平检测及临床意义[J].中国临床药理学与治疗学, 2013, 18 (2) :190-194. [10]WANG DS, PAN Y, NIU JQ, et al.IL-28B genetic variation, susceptibility and spontaneous clearance of hepatitis C virus[J].J Clin Hepatol, 2010, 26 (5) :496-499. (in Chinese) 王东生, 潘煜, 牛俊奇, 等.IL-28B基因变异与丙型肝炎的易感性及其自然清除的关系[J].临床肝胆病杂志, 2010, 26 (5) :496-499. [11]RAUCH A, KUTALIK Z, DESCOMBES P, et al.Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure:a genome-wide association study[J].Gastroenterology, 2010, 138 (4) :1338-1345. [12]MI Y, GAO YT, JIAO XL, et al.Association betvoeen an IL-28B gene polymorphism and susceptiblility to hepatitis C virus infection[J].World Chin J Dig, 2013, 21 (2) :182-187. (in Chinese) 米寅, 高英堂, 焦晓磊, 等.IL-28B基因多态性与丙型肝炎易感性的关系[J].世界华人消化杂志, 2013, 21 (2) :182-187. [13]MAURICIO V, RODRIGO AV, KATHERINE G, et al.IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients[J].World J Gastroenterol, 2011, 17 (31) :3636-3639. [14]HONDA M, SAKAI A, YAMASHITA T, et al.Hepatic ISG expression is associated with genetic variation in IL28B and the outcome of I FN therapy for chronic hepatitis C[J].Gastroenterology, 2010, 139 (2) :499-509. [15]DI MARCO VD, BRONTE F, CALVARUSO V, et al.IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection[J].Haematologica, 2012, 97 (5) :679-686.
本文二维码
计量
- 文章访问数: 2888
- HTML全文浏览量: 13
- PDF下载量: 598
- 被引次数: 0